The RUNX/CBFβ Complex in Breast Cancer: A Conundrum of Context

Adiba Khan(Cancer Research UK), Karen Blyth(Cancer Research UK Scotland Institute)
Cells
February 16, 2023
10.3390/cells12040641
Cited by 13

Related Papers

MCL-1 is a prognostic indicator and drug target in breast cancer
|Cell Death and Disease|2018|202
<i>Runx2</i> and <i>MYC</i> Collaborate in Lymphoma Development by Suppressing Apoptotic and Growth Arrest Pathways <i>In vivo</i>
|Cancer Research|2006|101